SciVision Biotech Inc (1786) — Long-term Investment Intensity

Latest as of December 2019: 0.1%

SciVision Biotech Inc (1786) has a Long-term Investment Intensity of 0.1% as of December 2019. Long-term investments of NT$2.00 Million represent 0.1% of total assets of NT$1.86 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SciVision Biotech Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.1%
LT Investments / Total Assets

Long-term Investments

NT$2.00 Million
TWD

Total Assets

NT$1.86 Billion
TWD

Country

Taiwan
TW

SciVision Biotech Inc Long-term Investment Intensity (2015–2019)

This chart shows how SciVision Biotech Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 0.1%, reflecting long-term investments of NT$2.00 Million against total assets of NT$1.86 Billion TWD. For the complete balance sheet picture, see SciVision Biotech Inc (1786) total assets.

Annual Long-term Investment Intensity for SciVision Biotech Inc (2015–2019)

The table below presents the year-by-year Long-term Investment Intensity for SciVision Biotech Inc from 2015 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read SciVision Biotech Inc (1786) financial obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (TWD) Total Assets Change (pp)
2019 0.1% NT$2.00 Million NT$1.86 Billion ▼ -0.3 pp
2017 0.4% NT$6.83 Million NT$1.56 Billion ▼ -0.7 pp
2016 1.1% NT$15.00 Million NT$1.36 Billion ▼ -0.3 pp
2015 1.4% NT$15.00 Million NT$1.07 Billion
pp = percentage points